metaMe Health develops digital treatments for gastrointestinal conditions, including irritable bowel syndrome.
Founded in 2016 by Timothy Rudolphi and Danny Bernstein, metaMe Health is based in Chicago, US. Its Regulora product delivers a behavior-based IBS intervention through seven automated sessions over three months, with adherence and outcome tracking through the metaMe Connect app. The company also had products in development for GERD and IBD with IBS overlap. In August 2019, it raised USD 3.8 million in seed funding led by LionBird, with Hemi Ventures and an unspecified investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at metaMe Health, Inc.? This is my company